Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in RHYTHM PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 541,450 shares of RYTM (RHYTHM PHARMACEUTICALS INC), worth $47.1M as of 2026-Q1. The position was decreased (-1.4% shares). RYTM represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$47.1M
Current Shares
541,450
Total Value Change
+$37.4M
Total Shares Change
+305,019
Other major holders of RYTM: BNP PARIBAS FINANCIAL MARKETS, RA CAPITAL MANAGEMENT, L.P., BlackRock, Inc., VANGUARD GROUP INC
Decreased |
| 541,450 |
-1.4% |
| $47.1M |
| 0.0% |
| $89.56 |
0 |
| 2025-Q4 | Increased | 549,020 | +25.5% | $58.8M | 0.0% | $106.76 | 36 |
| 2025-Q3 | Increased | 437,472 | +92.2% | $44.2M | 0.0% | $100.64 | 46 |
| 2025-Q2 | Increased | 227,627 | +81.0% | $14.4M | 0.0% | $62.73 | 43 |
| 2025-Q1 | Decreased | 125,782 | -42.5% | $6.7M | 0.0% | $54.80 | 0 |
| 2024-Q4 | Decreased | 218,544 | -3.0% | $12.2M | 0.0% | $56.34 | 0 |
| 2024-Q3 | Decreased | 225,373 | -4.7% | $11.8M | 0.0% | $51.35 | 0 |
| 2024-Q2 | Increased | 236,431 | +14.2% | $9.7M | 0.0% | $41.06 | 32 |